Understanding relaxin signalling at the cellular level

Adam L. Valkovic, Ross AD Bathgate, Chrishan S. Samuel, Martina Kocan

Research output: Contribution to journalReview ArticleResearchpeer-review

1 Citation (Scopus)

Abstract

The peptide hormone relaxin mediates many biological actions including anti-fibrotic, vasodilatory, angiogenic, anti-inflammatory, anti-apoptotic, and organ protective effects across a range of tissues. At the cellular level, relaxin binds to the G protein-coupled receptor relaxin family peptide receptor 1 (RXFP1) to activate a variety of downstream signal transduction pathways. This signalling cascade is complex and also varies in diverse cellular backgrounds. Moreover, RXFP1 signalling shows crosstalk with other receptors to mediate some of its physiological functions. This review summarises known signalling pathways induced by acute versus chronic treatment with relaxin across a range of cell types, it describes RXFP1 crosstalk with other receptors, signalling pathways activated by other ligands targeting RXFP1, and it also outlines physiological relevance of RXFP1 signalling outputs. Comprehensive understanding of the mechanism of relaxin actions in fibrosis, vasodilation, as well as organ protection, will further support relaxin's clinical potential.

Original languageEnglish
Pages (from-to)24-33
Number of pages10
JournalMolecular and Cellular Endocrinology
Volume487
DOIs
Publication statusPublished - 1 May 2019

Keywords

  • GPCR
  • Insulin-like peptides
  • Relaxin
  • RXFP1

Cite this

Valkovic, Adam L. ; Bathgate, Ross AD ; Samuel, Chrishan S. ; Kocan, Martina. / Understanding relaxin signalling at the cellular level. In: Molecular and Cellular Endocrinology. 2019 ; Vol. 487. pp. 24-33.
@article{c1f1b29471e744d482692010446262f6,
title = "Understanding relaxin signalling at the cellular level",
abstract = "The peptide hormone relaxin mediates many biological actions including anti-fibrotic, vasodilatory, angiogenic, anti-inflammatory, anti-apoptotic, and organ protective effects across a range of tissues. At the cellular level, relaxin binds to the G protein-coupled receptor relaxin family peptide receptor 1 (RXFP1) to activate a variety of downstream signal transduction pathways. This signalling cascade is complex and also varies in diverse cellular backgrounds. Moreover, RXFP1 signalling shows crosstalk with other receptors to mediate some of its physiological functions. This review summarises known signalling pathways induced by acute versus chronic treatment with relaxin across a range of cell types, it describes RXFP1 crosstalk with other receptors, signalling pathways activated by other ligands targeting RXFP1, and it also outlines physiological relevance of RXFP1 signalling outputs. Comprehensive understanding of the mechanism of relaxin actions in fibrosis, vasodilation, as well as organ protection, will further support relaxin's clinical potential.",
keywords = "GPCR, Insulin-like peptides, Relaxin, RXFP1",
author = "Valkovic, {Adam L.} and Bathgate, {Ross AD} and Samuel, {Chrishan S.} and Martina Kocan",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/j.mce.2018.12.017",
language = "English",
volume = "487",
pages = "24--33",
journal = "Molecular and Cellular Endocrinology",
issn = "0303-7207",
publisher = "Elsevier",

}

Understanding relaxin signalling at the cellular level. / Valkovic, Adam L.; Bathgate, Ross AD; Samuel, Chrishan S.; Kocan, Martina.

In: Molecular and Cellular Endocrinology, Vol. 487, 01.05.2019, p. 24-33.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Understanding relaxin signalling at the cellular level

AU - Valkovic, Adam L.

AU - Bathgate, Ross AD

AU - Samuel, Chrishan S.

AU - Kocan, Martina

PY - 2019/5/1

Y1 - 2019/5/1

N2 - The peptide hormone relaxin mediates many biological actions including anti-fibrotic, vasodilatory, angiogenic, anti-inflammatory, anti-apoptotic, and organ protective effects across a range of tissues. At the cellular level, relaxin binds to the G protein-coupled receptor relaxin family peptide receptor 1 (RXFP1) to activate a variety of downstream signal transduction pathways. This signalling cascade is complex and also varies in diverse cellular backgrounds. Moreover, RXFP1 signalling shows crosstalk with other receptors to mediate some of its physiological functions. This review summarises known signalling pathways induced by acute versus chronic treatment with relaxin across a range of cell types, it describes RXFP1 crosstalk with other receptors, signalling pathways activated by other ligands targeting RXFP1, and it also outlines physiological relevance of RXFP1 signalling outputs. Comprehensive understanding of the mechanism of relaxin actions in fibrosis, vasodilation, as well as organ protection, will further support relaxin's clinical potential.

AB - The peptide hormone relaxin mediates many biological actions including anti-fibrotic, vasodilatory, angiogenic, anti-inflammatory, anti-apoptotic, and organ protective effects across a range of tissues. At the cellular level, relaxin binds to the G protein-coupled receptor relaxin family peptide receptor 1 (RXFP1) to activate a variety of downstream signal transduction pathways. This signalling cascade is complex and also varies in diverse cellular backgrounds. Moreover, RXFP1 signalling shows crosstalk with other receptors to mediate some of its physiological functions. This review summarises known signalling pathways induced by acute versus chronic treatment with relaxin across a range of cell types, it describes RXFP1 crosstalk with other receptors, signalling pathways activated by other ligands targeting RXFP1, and it also outlines physiological relevance of RXFP1 signalling outputs. Comprehensive understanding of the mechanism of relaxin actions in fibrosis, vasodilation, as well as organ protection, will further support relaxin's clinical potential.

KW - GPCR

KW - Insulin-like peptides

KW - Relaxin

KW - RXFP1

UR - http://www.scopus.com/inward/record.url?scp=85060718648&partnerID=8YFLogxK

U2 - 10.1016/j.mce.2018.12.017

DO - 10.1016/j.mce.2018.12.017

M3 - Review Article

VL - 487

SP - 24

EP - 33

JO - Molecular and Cellular Endocrinology

JF - Molecular and Cellular Endocrinology

SN - 0303-7207

ER -